This most up-to-date twist while in the Lykos Therapeutics saga threatens a major overhaul of the business’s system and course, with Musk ally and billionaire investor Antonio Gracias showing up to desire to get the company again toward its nonprofit drug advancement roots and a more Doblinite philosophy.Among the essential options of your Portal